Literature DB >> 11185417

Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis.

M V Bettencourt1, S Bosne-David, L Amaral.   

Abstract

The comparative activity of five phenothiazines against multidrug-resistant strains of Mycobacterium tuberculosis (MDRTB) was studied using the Bactec 460 system. The order of antimycobacterial activity of the phenothiazines was: chlorpromazine = thioridazine > promethazine > promazine = desipramine. However, the levels required for an MIC 50 exceeded 1 mg/l and are beyond those that are clinically achievable. As phenothiazines are concentrated by macrophages that phagocytose and have in situ activity against mycobacteria, these agents may be considered for use as adjuvants for the management of freshly diagnosed tuberculosis in patients from populations with a high prevalence of MDRTB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11185417     DOI: 10.1016/s0924-8579(00)00199-0

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  15 in total

Review 1.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 2.  Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions.

Authors:  Gregory M Cook; Kiel Hards; Elyse Dunn; Adam Heikal; Yoshio Nakatani; Chris Greening; Dean C Crick; Fabio L Fontes; Kevin Pethe; Erik Hasenoehrl; Michael Berney
Journal:  Microbiol Spectr       Date:  2017-06

3.  Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis.

Authors:  Diane Ordway; Miguel Viveiros; Clara Leandro; Rosário Bettencourt; Josefina Almeida; Marta Martins; Jette E Kristiansen; Joseph Molnar; Leonard Amaral
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 4.  Thioridazine: resurrection as an antimicrobial agent?

Authors:  H K R Thanacoody
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

5.  The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.

Authors:  Dick van Soolingen; Rogelio Hernandez-Pando; Hector Orozco; Diana Aguilar; Cecile Magis-Escurra; Leonard Amaral; Jakko van Ingen; Martin J Boeree
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

6.  Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration.

Authors:  Charles D Sohaskey
Journal:  J Bacteriol       Date:  2008-02-22       Impact factor: 3.490

Review 7.  Combination approaches to combat multidrug-resistant bacteria.

Authors:  Roberta J Worthington; Christian Melander
Journal:  Trends Biotechnol       Date:  2013-01-18       Impact factor: 19.536

8.  Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells.

Authors:  Yan-Gang Zhou; Kun-Yan Li; Huan-De Li
Journal:  Eur J Clin Pharmacol       Date:  2008-05-14       Impact factor: 2.953

9.  In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates.

Authors:  Moustafa A El-Nakeeb; Hamida M Abou-Shleib; Amal M Khalil; Hoda G Omar; Omar M El-Halfawy
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476

10.  Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).

Authors:  K-j Min; B R Seo; Y C Bae; Y H Yoo; T K Kwon
Journal:  Cell Death Dis       Date:  2014-02-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.